ATE115126T1 - Muscarin-rezeptor-antagonisten. - Google Patents
Muscarin-rezeptor-antagonisten.Info
- Publication number
- ATE115126T1 ATE115126T1 AT90917056T AT90917056T ATE115126T1 AT E115126 T1 ATE115126 T1 AT E115126T1 AT 90917056 T AT90917056 T AT 90917056T AT 90917056 T AT90917056 T AT 90917056T AT E115126 T1 ATE115126 T1 AT E115126T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- pct
- receptor antagonists
- date jun
- sec
- Prior art date
Links
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 8
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- -1 -(CH2)nOH Chemical group 0.000 abstract 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898928042A GB8928042D0 (en) | 1989-12-12 | 1989-12-12 | Muscarinic receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE115126T1 true ATE115126T1 (de) | 1994-12-15 |
Family
ID=10667813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90917056T ATE115126T1 (de) | 1989-12-12 | 1990-11-28 | Muscarin-rezeptor-antagonisten. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5340831A (de) |
| EP (1) | EP0505376B1 (de) |
| JP (1) | JPH0678303B2 (de) |
| AT (1) | ATE115126T1 (de) |
| CA (1) | CA2069910C (de) |
| DE (1) | DE69014901T2 (de) |
| DK (1) | DK0505376T3 (de) |
| ES (1) | ES2064771T3 (de) |
| FI (1) | FI95027C (de) |
| GB (1) | GB8928042D0 (de) |
| GR (1) | GR3014907T3 (de) |
| IE (1) | IE64205B1 (de) |
| PT (1) | PT96144A (de) |
| WO (1) | WO1991009013A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639763A (en) * | 1994-03-01 | 1997-06-17 | Fmc Corporation | Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
| US6017931A (en) * | 1994-03-01 | 2000-01-25 | Fmc Corporation | Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
| US5569664A (en) * | 1995-02-16 | 1996-10-29 | Fmc Corporation | Insecticidal n-(substituted arylmethyl)-4-[bis(substituted phenyl) methyl]pi |
| CN1104239C (zh) * | 1996-12-02 | 2003-04-02 | 杏林制药株式会社 | 新颖的n-取代的吡咯烷衍生物及其制备方法 |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| EA200500173A1 (ru) | 2002-07-08 | 2005-08-25 | Рэнбакси Лабораториз Лимитед | Производные 3,6-дизамещенного азабицикло[3.1.0]гексана в качестве антагонистов мускариновых рецепторов |
| EP1546098B1 (de) | 2002-07-31 | 2008-05-28 | Ranbaxy Laboratories Limited | 3,6-disubstituierte azabicyclo [3.1.0]hexanderivate, die sich als muscarinrezeptorantagonisten eignen |
| HK1079708A1 (zh) | 2002-08-09 | 2006-04-13 | Ranbaxy Laboratories, Ltd. | 可用作毒蕈碱性受体拮抗剂的3,6-二取代氮杂二环[3.1.10]己烷衍生物 |
| EP1534675B1 (de) | 2002-08-23 | 2009-02-25 | Ranbaxy Laboratories, Ltd. | Fluor- und sulfonylaminohaltige, 3,6-disubstituierte azabicyclo¬3.1.0 hexanderivate als muscarinrezeptorantagonisten |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| AU2002353286A1 (en) | 2002-12-10 | 2004-06-30 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
| WO2004056767A1 (en) | 2002-12-23 | 2004-07-08 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| AU2002347553A1 (en) | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | Flavaxate derivatives as muscarinic receptor antagonists |
| US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| JP4767842B2 (ja) | 2003-04-01 | 2011-09-07 | セラヴァンス, インコーポレーテッド | β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
| EP1618091A1 (de) | 2003-04-09 | 2006-01-25 | Ranbaxy Laboratories, Ltd. | Substituierte azabicyclohexanderivate als antagonisten von muscarinrezeptoren |
| WO2004089899A1 (en) | 2003-04-10 | 2004-10-21 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| EP1615634B1 (de) | 2003-04-10 | 2007-05-16 | Ranbaxy Laboratories, Ltd. | Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten |
| WO2004089900A1 (en) | 2003-04-11 | 2004-10-21 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as muscarinic receptor antagonists |
| TW200510298A (en) | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
| JP2007524641A (ja) * | 2003-07-11 | 2007-08-30 | セラヴァンス, インコーポレーテッド | 置換4−アミノ−1−ベンジルピペリジン化合物 |
| EP1723142A1 (de) * | 2004-03-11 | 2006-11-22 | Theravance, Inc. | Als antagonisten des muskarinrezeptors geeignete diphenylmethylverbindungen |
| EP1725525A1 (de) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Als muscarinrezeptorantagonisten geeignete diphenylmethylverbindungen |
| WO2007024113A1 (en) | 2005-08-25 | 2007-03-01 | Rstech Corporation | Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity |
| WO2007045979A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| EP1877393A2 (de) * | 2005-12-27 | 2008-01-16 | Teva Pharmaceutical Fine Chemicals S.R.L. | Verfahren zur herstellung von darifenacin-hydrobromid |
| KR101495708B1 (ko) * | 2007-02-23 | 2015-02-25 | 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 | 무스카린 수용체 안타고니스트로 유용한 4차 암모늄 디페닐메틸 화합물 |
| CA2682032A1 (en) | 2007-04-24 | 2008-11-06 | Theravance, Inc. | Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| EP2361244B1 (de) | 2008-11-24 | 2013-07-10 | Council of Scientific & Industrial Research | Verfahren zur herstellung optisch aktiver n-benzyl-3-hydroxypyrrolidine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL76583A (en) * | 1984-10-19 | 1988-08-31 | Robins Co Inc A H | 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them |
| US4810713A (en) * | 1985-12-20 | 1989-03-07 | A. H. Robins Company, Incorporated | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment |
| EP0228893A3 (de) * | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Durch Aryloxyalkyl-Gruppen N-substituierte Arylalkyl heterozyklische Amine in Allergieheilverfahren |
| IN163948B (de) * | 1986-01-17 | 1988-12-10 | Robins Co Inc A H | |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
-
1989
- 1989-12-12 GB GB898928042A patent/GB8928042D0/en active Pending
-
1990
- 1990-11-28 ES ES90917056T patent/ES2064771T3/es not_active Expired - Lifetime
- 1990-11-28 WO PCT/EP1990/002043 patent/WO1991009013A1/en not_active Ceased
- 1990-11-28 CA CA002069910A patent/CA2069910C/en not_active Expired - Fee Related
- 1990-11-28 JP JP2515786A patent/JPH0678303B2/ja not_active Expired - Fee Related
- 1990-11-28 EP EP90917056A patent/EP0505376B1/de not_active Expired - Lifetime
- 1990-11-28 AT AT90917056T patent/ATE115126T1/de not_active IP Right Cessation
- 1990-11-28 DE DE69014901T patent/DE69014901T2/de not_active Expired - Fee Related
- 1990-11-28 DK DK90917056.5T patent/DK0505376T3/da active
- 1990-11-29 US US07/859,471 patent/US5340831A/en not_active Expired - Lifetime
- 1990-12-10 PT PT96144A patent/PT96144A/pt unknown
- 1990-12-11 IE IE446390A patent/IE64205B1/en not_active IP Right Cessation
-
1992
- 1992-05-22 FI FI922345A patent/FI95027C/fi not_active IP Right Cessation
-
1995
- 1995-02-01 GR GR940404057T patent/GR3014907T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69014901T2 (de) | 1995-04-27 |
| FI922345A0 (fi) | 1992-05-22 |
| WO1991009013A1 (en) | 1991-06-27 |
| EP0505376A1 (de) | 1992-09-30 |
| CA2069910A1 (en) | 1991-06-13 |
| DE69014901D1 (de) | 1995-01-19 |
| FI95027C (fi) | 1995-12-11 |
| GB8928042D0 (en) | 1990-02-14 |
| JPH04505927A (ja) | 1992-10-15 |
| JPH0678303B2 (ja) | 1994-10-05 |
| IE904463A1 (en) | 1991-06-19 |
| EP0505376B1 (de) | 1994-12-07 |
| US5340831A (en) | 1994-08-23 |
| FI95027B (fi) | 1995-08-31 |
| DK0505376T3 (da) | 1995-02-13 |
| CA2069910C (en) | 1996-11-12 |
| IE64205B1 (en) | 1995-07-12 |
| FI922345L (fi) | 1992-05-22 |
| GR3014907T3 (en) | 1995-05-31 |
| PT96144A (pt) | 1991-09-30 |
| ES2064771T3 (es) | 1995-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69014901D1 (de) | Muscarin-rezeptor-antagonisten. | |
| DK0510003T3 (da) | Piperidin-og pyrrolidinderivater | |
| WO1992005172A3 (en) | Muscarinic receptor antagonists | |
| ATE102183T1 (de) | Muscarin-rezeptor-antagonisten. | |
| DK581486A (da) | Antihypertensivt kombinationspraeparat | |
| DE68900117D1 (de) | Muscarin-rezeptor-antagonisten. | |
| ATE108776T1 (de) | Muscarin-rezeptor-antagonisten. | |
| DE69510510D1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| ES2087917T3 (es) | Derivados de 1,2-dihidro-2-oxo-quinoxalinas, su preparacion y su aplicacion en terapeutica. | |
| CA2069931A1 (en) | Muscarinic receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |